Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.80 Analyst target: $5.88 Upside: 632.98%
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
See the full interactive analysis & chart →Informational only — not investment advice.